Peculiarities of Candida vulvovaginitis in pregnant women at current stage
It discusses the problem of Candida vulvovaginitis (CVV) in pregnant women. It includes the modern statistic data and characteristics of the main infectious agent - Candida albicans, the conditions of its development and course during the pregnancy (immunological aspects of CVV, influence of the sex hormones and other), complications and sequelaes for the fetus and newborn. The problems of choosing drug for the treatment of CVV are also discussed, as well as treatment by natamicine of different forms in pregnant.

Keywords: Pimafucin, natamicine, Candida vulvovaginitis, Candida albicans, pregnancy